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Objective: To assess the feasibility and acceptability of routine web-based screening in general hospit
settings, and describe the level of common mental disorder.
Method: A service development platform to integrate mental and physical healthcare was implemented in s
specialties (rheumatology, limb reconstruction, hepatitis C, psoriasis, adult congenital heart disease (ACHD
chronic pain) across three general hospitals in London, UK. Under service conditions, patients completed
web-based questionnaire comprising mental and physical patient-reported outcome measures, whil
waiting for their appointment. Feasibility was quantiﬁed as the proportion of patients who completed th
questionnaire. Acceptability was quantiﬁed as the proportion of patients declining screening, and th
proportion requiring assistance completing the questionnaire. The prevalence of probable depression an
anxiety was expressed as the percentage of cases determined by the Patient Health Questionnaire-9 anal
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a
st
e
e
d
d
Generalised Anxiety Disorder Questionnaire-7.
Results: The proportion of patients screened varied widely across specialties (40.1–98.2%). The decline rate
was low (0.6–9.7%) and theminority required assistance (11.7–40.4%). The prevalence of probable depression
ranged from 60.9% in chronic pain to 6.6% in ACHD. The prevalence of probable anxiety ranged from 25.1% in
rheumatology to 11.4% in ACHD.
Conclusion: Web-based screening is acceptable to patients and can be effectively embedded in routine
practice. General hospital patients are at increased risk of common mental disorder, and routine screening
may help identify need, inform care and monitor outcomes.
© 2014 The Authors. Published Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/)..
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The relationship between mental and physical illness is complex
and bidirectional. Poor mental health is associated with increased risk
of physical illness, and poor physical health confers an elevated risk of
mental illness, most commonly depression and anxiety. Approxi-
mately 30% of the UK population have a long-term condition, and of
those, around 30% have a concomitant mental disorder [1,2]. The
overlap of mental and physical illness makes the management of both
more complicated and costly. Physically ill patients with comorbid
mental health problems experience elevated symptom burden [3],
lower adherence to treatment [4], impaired quality of life [5], poorerprognosis [6,7] and increased mortality [8,9]. They also use outpatient
services more frequently, and experience more hospital admissions
and primary care consultations [10–12]. In the UK, treatment of
physically ill patients with co-morbidmental health problems adds an
estimated £8–13 billion to the annual National Health Service (NHS)
expenditure on long-term conditions [13].
There is good evidence that common mental disorders can be
effectively treated in people with a physical health condition. Recent
meta-analyses of pharmacological and psychological interventions for
depression in physical illness have yielded effect sizes similar to those
seen in people without physical illness [14,15]. There is also evidence
that integrated mental healthcare positively impacts physical health
outcomes [16], reducing service use and healthcare costs [17,18].
However, psychological care is often absent in physical healthcare
settings, and mental disorders frequently go undetected and
untreated [19–21]. In the care of long-term conditions, physical.0/).
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quality of life [22]. Stigma attached to mental illness may inhibit
patients from spontaneously disclosing psychological distress, and
clinicians report feeling less comfortable enquiring about emotional
concerns [23]. A lack of conﬁdence, time or resources may contribute
to clinicians' reticence to probe patients' psychological problems.
Even when problems are identiﬁed, physical healthcare teams are
often ill-equipped to provide effective care, having received little or
no training in mental healthcare.
The case formainstreammental health assessment and support for
people with long-term conditions has been put forth in numerous
recent policy reports [13,24–29]. These emphasise the need for
training in basic mental health skills for physical healthcare pro-
fessionals, increased investment in liaison psychiatry services, and
routine outcome measurement to capture the value of mental
healthcare and inform commissioning. The UK National Institute for
Health and Clinical Excellence recommends routine screening to
improve identiﬁcation of mental disorders in chronic illness, along-
side a management strategy to provide care and follow-up [30]. Yet,
despite guideline recommendations and a growing body of support-
ing evidence [16,31], implementation of integrated care approaches
has been slow and patchy.
This paper describes the design and implementation of a novel
integrated care initiative introduced by King's Health Partners (KHP)
in 2011. KHP is an Academic Health Science Centre in London, UK,
comprising a leading research and teaching university (King's College
London), two NHS Acute Hospital Trusts (Guy's and St Thomas' NHS
Foundation Trust (GSTFT), King's College Hospital NHS Foundation
Trust (KCH) and an NHS Mental Health Trust (South London and
Maudsley NHS Foundation Trust). Integrating Mental & Physical
healthcare: Research Training and Services (IMPARTS) [32] is a service
development platform designed to support clinical teams in providing
timely, tailored, evidence-based care to patients with long-term
conditions. The aim is to develop a model of service delivery that
facilitates integrated care, whilst simultaneously promoting research.
The IMPARTS programme has ﬁve core components:
1) Web-based screening:
IMPARTS has developed a web-based screening interface,
which enables routine measurement of mental and physical
health outcomes, with real-time feedback to guide clinical care.
Screening patients electronically before their consultation
results in more productive use of waiting room time, more
efﬁcient assessment, improved recognition of patient concerns,
and more actions being taken in relation to these concerns
[33,34]. Computerised screening has been shown to be
acceptable to patients and clinicians [35,36], and studies
suggest that regular screening with feedback of results may
improve patient outcomes [16,34,36]. However, evidence that
routine screening can be successfully implemented under true
service conditions is scarce. Most studies have relied on
researchers to administer screening and cannot therefore
comment on the feasibility of routine implementation
[34,37,38]. IMPARTS aims to translate research ﬁndings and
guideline recommendations into real-world clinical practice.
To be sustainable, outcome measurement must be embedded
within existing infrastructure and “owned” by practitioners
rather than researchers.2) Care pathway development:
IMPARTS develops robust care pathways to guide management of
mental health problems identiﬁed through screening. Gilbody et
al. showed thatdepressionscreening innon-mentalhealth settings
was associatedwith increased identiﬁcation of depression, but had
no impact on patient outcomes [39]. However, screening wasevaluated as a stand-alone action without a care pathway or
management plan. To impact health outcomes, evidence indicates
that enhanced management and follow-up is needed [16,30,40].
The IMPARTS system is designed to support management and
follow-up of common mental disorder. IMPARTS devises tailored
mental health care pathways to ensure patients identiﬁed through
screening receive appropriate care. These provide recommenda-
tions on interpreting screening output, making referrals and
assessing suicide risk. Screening occurs at regular intervals so that
changes in symptoms and functioning can be captured and care
plans adjusted accordingly.3) Training in core mental health skills:
Successful mental health screening and signposting depends on
clinicians being conﬁdent in interpreting outcome measures,
and engaging patients in discussion about psychological
problems. Scant provision of liaison psychiatry and clinical/
health psychology services means that responsibility for
detecting and managing mental health problems often falls
upon non-specialists. Given that approximately one in three
people with chronic illness will have a probable mental
disorder, it is critical that generalists are equipped with core
skills in psychological care [24]. Even brief training interven-
tions have been shown to increase clinicians' conﬁdence in
dealing with mental health problems [41]. IMPARTS has
developed a mental health skills training package for physical
healthcare teams. Popular topics include: eliciting concerns
and discussing distress; how and when to refer to a mental
health specialist; encouraging adherence; assessing risk; and
problem-solving. Training is delivered in ﬂexible, interactive
sessions scheduled to accommodate the entire team, from
consultant physicians to healthcare assistants.4) Bespoke self-help materials
Although there are many self-help materials available for
depression and anxiety [42,43] and some excellent resources
for people with speciﬁc long-term conditions [44], few bridge
the gap between mental and physical health. If self-help
interventions do not resonate with patients' experiences,
their efﬁcacy and acceptability may be diminished. IMPARTS
has developed a portfolio of bespoke self-help materials which
address patients' psychological needs in the context of their
illness. These materials are developed with patient and
clinician input, produced in a written format and use a
theoretical model. They are tailored to the nuances of the
particular physical condition and designed to be used by non-
specialists to supplement discussions about psychological
issues and identify coping strategies. Studies have shown that
self-help interventions are more effective if provided with
guidance from a healthcare professional [45]. Thus, clinicians
participating in the IMPARTS programme are taught how to
engage patients in discussion about the key concepts.5) Research infrastructure
Routine outcome measurement enables collection of data for
audit and research. IMPARTS has developed a pseudonymised
research database combining patient-reported outcomes from
screening, with clinical and demographic data from the hospital
electronic patient record (EPR). This database enables audit of
clinical practice against national standards of care, and
evaluation of patterns of need and service usage to inform
commissioning. It also provides a rich resource for hypothesis-
driven observational research investigating the prevalence,
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illness. The IMPARTS framework simpliﬁes the process of
participation in research, integrating data collection into
routine practice and providing generic ethical approval for
analysis of pseudonymised data collected via the IMPARTS
platform (NRES Ref: 12/SC/0422). It also provides a platform for
identifying and recruiting patients to clinical trials. A question
can be added at the end of the questionnaire seeking patients'
consent for a researcher to contact them to discuss participation
in future research projects. Those who agree are added to a case
register of potential research recruits.These ﬁve components provide the infrastructure to embed
mental health assessment within an integrated system of care,
encompassing training, care pathway development and research.
Identifying distress is just one link in a chain of actions needed to
manage mental disorders in medical settings. IMPARTS facilitates a
synergistic system of care that supports each link: training, detection,
assessment, appropriate referral, intervention and evaluation.
This paper is the ﬁrst in a series to explore the feasibility of the
IMPARTS programme and focuses on the ﬁrst of the ﬁve components.
We aim to describe: (1) the feasibility and acceptability of routine
web-based screening offered under service conditions and (2) the
level of psychological morbidity and substance misuse identiﬁed.
2. Method
2.1. Procedure
Patients attending general hospital clinics are given an information
sheet inviting them to complete a questionnaire on a touch-screen e-
tablet whilst waiting for their appointment. After logging in using
their hospital identiﬁcation number, patients complete a series of
outcomemeasures, tailored to their condition. Outcomemeasures are
adapted using branching structures to make them as short as possible.
The data captured populate the electronic patient record (EPR) in
real-time, meaning that the results are immediately available to the
clinician prior to consultation. The system is ﬂexible and can be
programmed to administer different measures depending on vari-
ables such as gender, diagnosis or the date of last assessment.
The data captured inform automated algorithms in EPR, which
operationalise care pathways agreed with the clinical team. Care
pathways vary according to available resources, but may include
referral to community services, or mental health services embedded
within the acute trust. Algorithms are based on symptom severity and
the presence of suicidal ideation.
2.2. Setting
IMPARTS was piloted in rheumatology (KCH) in 2011, initially in
the nurse-led treatment clinics, before being extended to all clinics in
2012. Patients are screened before every appointment, and the typical
patient attends once every 3–6 months. A wealth of evidence links
rheumatological disorders with increased risk of mental illness [46],
but there were also pragmatic reasons for selecting this service as the
pilot site: an established working relationship with an IT developer
able to develop the screening interface, and a liaison psychiatrist
embedded within the clinical team.
IMPARTS expanded organically, spurred by the enthusiasm of
particular clinical teams. In 2012, it extended to limb reconstruction
and hepatitis C (KCH). The limb reconstruction service sees patients
with severely injured or deformed limbs, and screening occurs every
three months. In the hepatitis C, screening takes place in the direct-
acting antiviral treatment clinic. Patients attend as frequently as once
per week and are screened on every occasion. In 2013, IMPARTSextended to the adult congenital heart disease (ACHD) service, the
INPUT pain management programme, and the psoriasis clinic at
GSTFT. The ACHD service screens patients annually at their review
appointment. The INPUT pain service is a 4 week residential
programme for patients with chronic pain unresponsive to medical
treatment. Patients are screened at admission and discharge. Patients
attending the psoriasis clinic are screened approximately every three
months. More recently IMPARTS was implemented in Multiple
Sclerosis, Cranioplasty and Cough (KCH), and Kidney Transplant,
Dialysis, and Teenage and Young Adult Cancer (GSTFT)—however, the
data are not presented in this paper because the number of patients
assessed so far in these services is small.
2.3. Measures
Outcome measures were selected in consultation with the clinical
teams to capture data pertinent to their patient group. IMPARTS has
developed a menu of questionnaires, including measures of mental
health and substance use, disease-speciﬁc quality of life, disability,
physical symptoms, illness perceptions, and treatment adherence. The
mental health and substance use screening tools are described below.
Depression was assessed in all services using the Patient Health
Questionnaire-9 (PHQ-9) [47], which has been shown to have good
sensitivity, speciﬁcity [48] and test-retest reliability [49], and has been
widely validated in physically ill populations [50,51]. Criteria for
probable major depression (MDD) were met if the patient reported
low mood or loss of interest plus at least ﬁve out of nine symptoms in
total, for more than half the days in the last twoweeks. Suicidality was
assessed by item 9 of the PHQ-9 and deﬁned as having “thoughts that
youwould be better off dead or of hurting yourself in someway”more
than half the days in the past two weeks.
Anxiety was assessed using the Generalised Anxiety Disorder
Questionnaire-7 (GAD-7) [52], which has been shown to have good
reliability, and criterion, construct, factorial and procedural validity
[52]. Criteria for probable generalised anxiety disorder (GAD) were
met if the patient scored ≥10 on the GAD-7.
Probable post-traumatic stress disorder (PTSD) was assessed in
limb reconstruction only, and deﬁned as a score of 4 on the Post
Traumatic Stress Disorder Checklist-4 (PCL-4) [53].
Alcohol and drug misuse were assessed in limb reconstruction
and hepatitis C. Alcohol misuse was assessed using the Alcohol
Use Disorders Identiﬁcation Test (AUDIT) [54]. Drug misuse was
assessed using a bespoke measure, since a suitable, validated tool
was not available. Probable drug dependence was deﬁned as an
afﬁrmative response to the question “In the past year have you used
any drug or medication to the extent that you felt that you needed
it or were dependent on it?” Patients were then asked “Would you
like help to stop using any drug or medication?”. Smoking was
assessed in all services except hepatitis C with the question “Do you
currently smoke?”
2.4. Data analysis
Feasibility was quantiﬁed as the proportion of patients attending
their appointment who completed the IMPARTS questionnaire.
Feasibility data were available for four services: rheumatology, limb
reconstruction, hepatitis C and psoriasis. Acceptability was quantiﬁed
as: (1) the proportion of patients declining screening, and (2) the
proportion of patients requiring assistance completing the question-
naire. Data on the proportion of patients who declined screening were
available for rheumatology, limb reconstruction, hepatitis C and
psoriasis, and data on the proportion of patients requiring assistance
completing the questionnaire were available for rheumatology and
hepatitis C.
Whether or not process data on feasibility and acceptability were
collected was inﬂuenced by the characteristics of the clinic and the
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feasibility and acceptability relate to the pilot period, during which
screening was facilitated by the IMPARTS project team. When the
nursing team assumed responsibility for screening, they did not have
sufﬁcient time to record process data in addition to their clinical
duties. Similarly, collection of process data in limb reconstruction was
possible initially when screening was facilitated by the service
coordinator, but ceased when the clinical team took over. Pharmacy
students facilitated screening in hepatitis C, and did collect process
data. In psoriasis, pain, and ACHD, the clinical team facilitated
screening, but process data were collected in psoriasis only.
The prevalence of probable depression, anxiety, PTSD, alcohol,
drug misuse and smoking was expressed as the percentage of cases
determined by the PHQ-9, GAD-7, PCL-4, AUDIT, drug dependence
and smoking questionnaire, respectively. Prevalence estimates were
calculated from baseline screening responses. Denominators for
different measures vary due to patients not completing the full
questionnaire, or measures being added to the questionnaire at a
later date.
3. Results
3.1. Feasibility and acceptability of screening
The proportion of patients completing the IMPARTS questionnaire
varied widely across the services studied, from 98.2% in psoriasis to
40.1% in hepatitis C (see Table 1). The reasons why patients were not
screened also varied. In limb reconstruction and hepatitis C, the most
common reason was a lack of time (24.3% and 54.8% respectively). By
contrast, fewer than 3% of patients were missed for this reason in
psoriasis and rheumatology. The proportion of patients declining to
complete the questionnaire was low, ranging from 5.1% in rheuma-
tology to 0.6% in psoriasis. A conservative estimate of acceptability
was calculated by excluding patients who were unlikely to have been
invited to complete the questionnaire (i.e. those not screened due to
lack of time, insufﬁcient English, staff shortage etc). Refusal rates
remained less than 10%, with hepatitis C having the highest
proportion of decliners (9.7%). In rheumatology and hepatitis C, the
proportion of patients declining increased at subsequent encounters
though the large majority continued to complete the questionnaire.
At the third encounter, the decline rate was 19% in rheumatology
and 36% in hepatitis C. There was also wide variation in the proportionTable 1
Proportion of patients screened and proportion requiring assistance at ﬁrst encounter
Rheumatology Limb
Reconstruction
Hepatitis
C
Psoriasis
Attended appointment 297 272 192 165
Screened 260 (87.5%) 170 (62.5%) 77
(40.1%)
162
(98.2%)
Reason not screened⁎:
Patient declined 15 (5.1%) 7 (2.6%) 7 (4.2%) 1 (0.6%)
Not enough time 7 (2.4%) 66 (24.3%) 92
(54.8%)
1 (0.6%)
IT problem 8 (2.7%) n/a 2 (1.2%) 1 (0.6%)
Insufﬁcient English 5 (1.7%) 2 (0.7%) n/a n/a
Space shortage n/a 18 (6.6%) n/a n/a
Staff shortage n/a 9 (3.3%) n/a n/a
Disability 1 (0.3%) n/a 2 (1.2%) n/a
Other 1 (0.3%) n/a n/a n/a
Needed assistance with
screening
105 (40.4%) No data 9
(11.7%)
No data
Reason for assistance:
Lack of conﬁdence with
IT
68 (26.2%) No data 7 (9.1%) No data
Insufﬁcient English 16 (6.2%) No data 2 (2.6%) No data
Disability 21 (8.1%) No data n/a No data
⁎ Data on reason not screened available for 168 of the 192 hepatitis C patients.of patients needing assistance completing the questionnaire (40.4%
in rheumatology versus 11.7% in hepatitis C). In both services,
lack of conﬁdence with IT was the most common reason for
requiring assistance.
3.2. Psychological morbidity identiﬁed via screening
Table 2 presents the prevalence of mental health problems
and substance misuse in the services where IMPARTS has been
implemented. Probable MDD was most common in the pain clinic
(60.9%). The prevalence of MDD was similar in rheumatology
(23.2%), limb reconstruction (22.1%), and hepatitis C (18.5%), notably
lower in the psoriasis clinic (10.8%), and lowest of all in ACHD
(6.6%). Just over a third of patients presenting in the chronic pain
clinic met PHQ-9 criteria for severe depression, and 17.4% screened
positive for suicidal ideation. After pain, severe depression was most
common in rheumatology, and suicidal ideation was most common
in limb reconstruction.
The prevalence of probable generalised anxiety disorder (GAD)
ranged from 25.1% in rheumatology to 11.4% in ACHD. The highest
prevalence of severe anxiety was in limb reconstruction (12.7%).
Comorbid depression and anxiety was most common in rheumatol-
ogy (16.3%), with 70% of the patients who screened positive for
probable MDD also screening positive for probable GAD. A similar
level of comorbidity was seen in limb reconstruction. In hepatitis C,
the prevalence of GAD was lower relative to MDD, and comorbidity
was reduced. In psoriasis and ACHD, GADwas comparatively common
compared to MDD.
In both limb reconstruction and hepatitis C, the prevalence of
probable alcohol dependence was low—1.8% and 0%, respectively.
Levels of harmful drinking were also low. More patients screened
positive for hazardous drinking, particularly in limb reconstruction
(10.2%). As expected, probable drug dependence was most common
in hepatitis C (17.2%).
Nine percent of patients screened in limb reconstruction met
criteria for probable PTSD. Road trafﬁc accidents are the most
common reason for treatment, but the service also frequently sees
servicemen and women injured in combat.
4. Discussion
IMPARTS aims to facilitate integrated care by equipping clinical
teams with the infrastructure and skills to identify, manage and
monitor mental disorders and their impact on physical health and
functioning. The extent to which this ambition is realised depends on
how successfully IMPARTS is integrated into routine practice. Our
feasibility and acceptability data indicate wide variation between
services. Whilst screening was very successfully embedded within the
dermatology service (98% screened), in hepatitis C implementation
was more challenging (40% screened). Screening rates reported in the
existing literature also vary widely [55,56]. An initiative to implement
routine use of the Edmonton Symptom Assessment Scale for lung
cancer patients in Ontario, Canada, reported screening rates ranging
from 20–90% depending on the centre [57]. Divergence in the
proportion of patients screened may be due to differences in service
organisation, environment, culture, size, or stafﬁng levels, as well as
the degree of team “buy-in” [58]. It should be noted that in services
where staff were not able to record process data, time constraints may
have also impacted the proportion of patients screened.
The proportion of patients agreeing to complete the IMPARTS
questionnaire also varied, though was consistently higher than has
been achieved for research samples in similar settings [33,36]. Decline
rates may be affected by the characteristics of patients attending the
service, or by the way screening is introduced to the patient. Decline
rates were lower when a healthcare professional approached the
patient, rather than a student or volunteer. As has been observed
Table 2
Prevalence and severity of psychological morbidity at ﬁrst screening encounter
Rheumatology Limb reconstruction ACHD Hepatitis C Chronic pain Psoriasis
Depression (PHQ-9) n=785 n=276 n=273 n=103 n=294 n=332
Probable MDD 182
23.2% (20.2–26.1)
61
22.1% (17.2–27.0)
18
6.6% (3.6–9.6)
19
18.5% (10.8–26.1)
179
60.9% (55.3–66.5)
36
10.8% (7.5–14.2)
Severe depression (score 20–27) 72
9.2%
21
7.6%
3
1.1%
5
4.9%
100
34.0%
15
4.5%
Moderate depression (score 15–19) 73
9.3%
30
10.9%
12
4.4%
8
7.8%
64
21.8%
17
5.1%
Mild depression (score b15) 37
4.7%
10
3.6%
3
1.1%
6
5.8%
15
5.1%
4
1.2%
Suicidal ideation 46
5.9%
18
6.5%
6
2.2%
3
2.9%
51
17.4%
14
4.2%
Anxiety (GAD-7) n=780 n=276 n=271 n=100 n/a n=330
Probable GAD 196
25.1% (22.1–28.2)
57
20.7% (15.9–25.5)
31
11.4% (7.6–15.3)
14
14.0% (7.1–20.9)
n/a 48
14.6% (10.7–18.4)
Severe GAD (score ≥15) 91
11.7%
35
12.7%
16
5.9%
7
7.0%
n/a 29
8.8%
Depression AND Anxiety n=780 n=276 n=271 n=100 n/a n=330
MDD AND GAD 127
16.3% (13.7–18.9)
42
15.2% (11.0–19.5)
12
4.4% (2.0–6.9)
9
9.0% (3.3–14.7)
n/a 29
8.8% (5.7–11.9)
Alcohol misuse (AUDIT) n/a n=275 n/a n=92 n/a n/a
Any alcohol problem (score ≥8) n/a 34
12.4% (9.0–16.8)
n/a 6
6.5% (2.8–13.8)
n/a n/a
Alcohol dependence (score ≥20) n/a 5
1.8% (0.2–3.4)
n/a 0 n/a n/a
Harmful drinking (score16-19) n/a 1
0.4%
n/a 2
2.2%
n/a n/a
Hazardous drinking (score 8–15) n/a 28
10.2%
n/a 4
4.4%
n/a n/a
Drug misuse n/a n=215 n/a n=58 n/a n/a
Probable drug dependence n/a 10
4.7% (2.4–8.5)
n/a 10
17.2% (9.4–29.1)
n/a n/a
Would like help to stop using n/a 5
2.3%
n/a 7
12.1%
n/a n/a
PTSD (PCL-4) n/a n=267 n/a n/a n/a n/a
Probable PTSD n/a 24
9.0% (6.1–13.1)
n/a n/a n/a n/a
Smoking n=529 n=270 n=151 n/a n=190 n=323
Currently smoke 84
15.9% (12.8–19.0)
42
15.6% (11.2–19.9)
15
9.9% (5.1–14.8)
n/a 60
31.6% (24.9–38.2)
70
21.7% (17.2–26.2)
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participation at follow-up, particularly in hepatitis C, where the
questionnaire was longest and patients were screened most fre-
quently. The higher proportion of rheumatology patients requiring
assistance completing the questionnaire probably reﬂects increased
levels of disability and the more advanced age of the patient
population, with older people tending to be less conﬁdent using IT
[59]. Several previous studies have assessed patients' experience of
computerised screening [38,60,61] but few have presented data on
the proportion needing staff assistance, which is crucial in considering
the resource implications of routine implementation.
Conclusions about feasibility and acceptability are constrained by
our narrow deﬁnition of these outcomes. A more nuanced appraisal
might include measurement of the impact of screening on consulta-
tion duration and staff roles and responsibilities, as well as interviews
with clinicians and patients to elicit their experience of screening. Yet
even with these additions, it would still only be possible to comment
on the feasibility of screening, and the factors that enhance or inhibit
implementation. As discussed previously, screening as a stand-alone
intervention has limited utility—IMPARTS' remit is broader, aiming to
embed mental health assessment within an integrated system of care
that supports appropriate management and monitoring.
The prevalence data demonstrate increased risk of common
mental disorder in a range of general hospital settings, and highlight
the need for improved mental healthcare provision. Depression was
most common in the chronic pain service at GSTFT. This is
unsurprising given the stringent criteria for referral to the service,
and the strong association between pain and depression [62].Previous surveys conducted in chronic pain populations have yielded
similarly high prevalence estimates [63]. The prevalence of depres-
sion in rheumatology, limb reconstruction, and hepatitis C was
approximately twice that found in the general population [64,65].
The prevalence of depression in the psoriasis clinic was considerably
lower, though still elevated compared to the general population.
Though patients with ACHD face potential medical complications,
they are generally asymptomatic, and this is reﬂected in a much
lower prevalence of depression, equivalent to that seen in the
general population.
The prevalence of anxiety followed a similar pattern to depression.
Notable differences were the relatively low level of anxiety in
hepatitis C, and the relatively high level of anxiety in psoriasis. In
both limb reconstruction and hepatitis C, the prevalence of alcohol
misuse was similar to that found in the local general population [66].
Intravenous drug use is a common cause of hepatitis C infection, and
hence the prevalence of patient-reported drug dependence was
elevated in this population. In limb reconstruction, the prevalence of
PTSD was higher than that found in the local community [67], but
similar to previous estimates in patients undergoing limb reconstruc-
tion surgery [68].
Our next step will be to undertake an evaluation of the other
components of the IMPARTS package, and assess whether screening
changes clinician behaviour and patient care. This will include a
survey of patient and clinician experiences of the screening process,
and an audit of EPR to assess ﬁdelity to IMPARTS care pathways and
determine the proportion of patients who receive appropriate
intervention. We have already begun evaluating the usefulness of
323L. Rayner et al. / General Hospital Psychiatry 36 (2014) 318–324the IMPARTS training programme, looking at clinician satisfaction and
self-reported changes in conﬁdence and competence. Additionally, we
plan to examine patients' and clinicians' experience of using the
IMPARTS self-help materials, and assess the extent to which they are
integrated into routine practice.
5. Conclusion
General hospital patients are at increased risk of mental health
problems. The IMPARTS programme facilitates integration of mental
and physical healthcare, and promotes research and audit as part of
patient care. Preliminary data indicate that screening can be
effectively embedded in routine practice. Further work is needed to
evaluate its impact on clinical activity and outcomes.
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